These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32057662)

  • 1. The difficult balance between thrombosis and bleeding after transcatheter aortic valve replacement: A translational review.
    Trimaille A; Marchandot B; Park SH; Schini-Kerth V; Morel O
    Arch Cardiovasc Dis; 2020 Apr; 113(4):263-275. PubMed ID: 32057662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of stroke after transcatheter prosthetic aortic valve implant with aortic bioprosthesis: subclinical thrombosis and possible therapeutic implications.
    Di Pasquale G; Coutsoumbas GV; Zagnoni S
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e46-e49. PubMed ID: 29045310
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.
    Reyes M; Reardon MJ
    Methodist Debakey Cardiovasc J; 2017; 13(3):126-131. PubMed ID: 29743997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Witberg G; Lador A; Yahav D; Kornowski R
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):408-416. PubMed ID: 29388308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience.
    Gurevich S; Oestreich B; Kelly RF; Mbai M; Bertog S; Yannopoulos D; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):621-625. PubMed ID: 29276174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial.
    Giustino G; Tijssen J; Windecker S; Dangas G
    Cardiovasc Res; 2020 Mar; 116(3):e39-e41. PubMed ID: 32077477
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.
    Arnold SV; Zhang Y; Baron SJ; McAndrew TC; Alu MC; Kodali SK; Kapadia S; Thourani VH; Miller DC; Mack MJ; Leon MB; Cohen DJ
    JACC Cardiovasc Interv; 2019 Feb; 12(4):362-369. PubMed ID: 30784641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, Timing, and Impact of Access-Site and Non-Access-Site Bleeding on Mortality Among Patients Undergoing Transcatheter Aortic Valve Replacement.
    Piccolo R; Pilgrim T; Franzone A; Valgimigli M; Haynes A; Asami M; Lanz J; Räber L; Praz F; Langhammer B; Roost E; Windecker S; Stortecky S
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1436-1446. PubMed ID: 28728657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review.
    Chitturi KR; Aladin AI; Braun R; Al-Qaraghuli AK; Banerjee A; Reddy P; Merdler I; Chaturvedi A; Abusnina W; Haberman D; Lupu L; Rodriguez-Weisson FJ; Case BC; Wermers JP; Ben-Dor I; Satler LF; Waksman R; Rogers T
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e014143. PubMed ID: 38853766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Linke A; Chandrasekhar J; Sartori S; Lefevre T; van Belle E; Schaefer U; Tchetche D; Sardella G; Webb J; Colombo A; Windecker S; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Asgar A; Dumonteil N; Tamburino C; Hink U; Violini R; Stella P; Bernstein D; Deliargyris E; Hengstenberg C; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1016-1026. PubMed ID: 28498562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major Bleeding Associated With Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement.
    Ferrante G; Rossi A; Corrada E; Reggi A; Regazzoli D; Reimers B; Pagnotta P
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1623-1624. PubMed ID: 31377274
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
    Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.
    Guedeney P; Huchet F; Manigold T; Overtchouk P; Rouanet S; Balagny P; Leprince P; Lebreton G; Letocart V; Barthelemy O; Vicaut E; Montalescot G; Guerin P; Collet JP;
    Arch Cardiovasc Dis; 2020 May; 113(5):341-349. PubMed ID: 32115397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves.
    Fischer Q; Urena M; Bouleti C; Abtan J; Brochet E; Carrasco JL; Iung B; Vahanian A; Himbert D
    Arch Cardiovasc Dis; 2019; 112(8-9):512-522. PubMed ID: 31474571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.